Astria Therapeutics Stock Skyrockets 53% After $700M Buyout – What’s Next?
Latest News & Developments On Oct. 14, 2025, Astria was swept into the headlines by a surprise $700+ million takeover. BioCryst Pharmaceuticals announced a definitive merger agreement to acquire Astria for $8.55